Добро пожаловать
Зарегистрировать аккаунт
Войдите, используя email
Зарегистрируйтесь с помощью email
Проверь свои входящие
AivoCode
About
AivoCode is an emerging biotech focused on critical neurological diseases such as traumatic brain injury and Alzheimer’s disease.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $149.75K
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
AivoCode Inc. is an emerging biotechnology company focused on critical neurological diseases such as brain injury, Alzheimer’s disease and other degenerative disorders. AivoCode’s technology is based on proprietary and unique peptides that specifically recognize molecular changes in brain injuries and neurodegenerative diseases. These peptides enhance the delivery of a variety of therapeutics and diagnostic agents into affected regions of the brain and can also possesses intrinsic therapeutic properties. AivoCode’s technology development was funded entirely by non-dilutive federal grant funding.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 6, 2017 | Grant | $0.98M | 1 |
National Science Foundation
|
— | Detail |
| Dec 1, 2015 | Grant | $149.75K | 1 |
National Science Foundation
|
— | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
